Literature DB >> 3317830

Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance.

D J Krogstad1, I Y Gluzman, D E Kyle, A M Oduola, S K Martin, W K Milhous, P H Schlesinger.   

Abstract

Chloroquine-resistant Plasmodium falciparum accumulate significantly less chloroquine than susceptible parasites, and this is thought to be the basis of their resistance. However, the reason for the lower accumulation of chloroquine was unknown. The resistant parasite has now been found to release chloroquine 40 to 50 times more rapidly than the susceptible parasite, although their initial rates of chloroquine accumulation are the same. Verapamil and two other calcium channel blockers, as well as vinblastine and daunomycin, each slowed the release and increased the accumulation of chloroquine by resistant (but not susceptible) Plasmodium falciparum. These results suggest that a higher rate of chloroquine release explains the lower chloroquine accumulation, and thus the resistance observed in resistant Plasmodium falciparum.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3317830     DOI: 10.1126/science.3317830

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  106 in total

Review 1.  History, dynamics, and public health importance of malaria parasite resistance.

Authors:  Ambrose O Talisuna; Peter Bloland; Umberto D'Alessandro
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 2.  Active efflux mechanisms for antimicrobial resistance.

Authors:  S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

Review 3.  Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.

Authors:  Robert L Summers; Megan N Nash; Rowena E Martin
Journal:  Cell Mol Life Sci       Date:  2012-06       Impact factor: 9.261

4.  Specific inhibition of the plasmodial surface anion channel by dantrolene.

Authors:  Godfrey Lisk; Myungsa Kang; Jamieson V Cohn; Sanjay A Desai
Journal:  Eukaryot Cell       Date:  2006-09-01

5.  A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum.

Authors:  Steven J Burgess; Audrey Selzer; Jane Xu Kelly; Martin J Smilkstein; Michael K Riscoe; David H Peyton
Journal:  J Med Chem       Date:  2006-09-07       Impact factor: 7.446

Review 6.  Transporters involved in resistance to antimalarial drugs.

Authors:  Stephanie G Valderramos; David A Fidock
Journal:  Trends Pharmacol Sci       Date:  2006-09-25       Impact factor: 14.819

7.  Differences in trans-stimulated chloroquine efflux kinetics are linked to PfCRT in Plasmodium falciparum.

Authors:  Cecilia P Sanchez; Petra Rohrbach; Jeremy E McLean; David A Fidock; Wilfred D Stein; Michael Lanzer
Journal:  Mol Microbiol       Date:  2007-04       Impact factor: 3.501

8.  Chloroquine Resistant Plasmodium falciparum in Nigeria: Relationship between pfcrt and pfmdr1 Polymorphisms, In-Vitro Resistance and Treatment Outcome.

Authors:  O A Folarin; G O Gbotosho; A Sowunmi; O O Olorunsogo; A M J Oduola; T C Happi
Journal:  Open Trop Med J       Date:  2008

9.  Reversal agent and linker variants of reversed chloroquines: activities against Plasmodium falciparum.

Authors:  Simeon Andrews; Steven J Burgess; Deborah Skaalrud; Jane Xu Kelly; David H Peyton
Journal:  J Med Chem       Date:  2010-01-28       Impact factor: 7.446

10.  Chloroquine resistance-conferring mutations in pfcrt give rise to a chloroquine-associated H+ leak from the malaria parasite's digestive vacuole.

Authors:  Adele M Lehane; Kiaran Kirk
Journal:  Antimicrob Agents Chemother       Date:  2008-10-13       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.